Social networks
861 17,147Activities
Entity types
Location
5 Bis Av. Marcel Proust, 28000 Chartres, France
Chartres
France
Employees
Scale: 11-50
Estimated: 32
SIREN
609187406Engaged corporates
59Added in Motherbase
6 years, 2 months ago[Automatic translation follows] The French (bio)pharmaceutical industrial sector.
Polepharma has been structuring the French (bio)pharmaceutical industrial sector and supporting its transformation for 20 years.
Polepharma has become the leading industrial cooperation in medicine in Europe, between regions of excellence and the players in the sector:
400+ members, 60% of production & 70k jobs in France.
Established in 5 territories (Centre-Val de Loire, Ile-de-France, Normandy, Occitanie, Nouvelle-Aquitaine), Polepharma leads its members throughout France.
These are laboratories, suppliers, schools, collectives, experts, talents who want to make France the best place in the world to develop & produce medicines, i.e. cutting-edge, virtuous, attractive for business and talents.
Manufacture quality treatments in France, preventive & curative, in the best conditions, secures our health, contributes to employment and local economies.
France has made it a priority to ensure its health sovereignty.
To achieve this, it must regain its European leadership and accelerate the transition of its (bio)pharmaceutical industry. Only collective action will make it possible to meet these challenges.
AUDACITY, PRIDE AND COOPERATION
Cluster, Networking, and Pharmaceutical Industry
La filière industrielle (bio)pharmaceutique française.
Polepharma structure la filière industrielle (bio)pharmaceutique française et accompagne sa transformation depuis 20 ans.
Polepharma est devenue la 1ère coopération industrielle du médicament en Europe, entre des terres d’excellence et les acteurs de la filière :
400+ membres, 60% de la production & 70k emplois en France.
Implanté dans 5 territoires (Centre-Val de Loire, Ile-de-France, Normandie, Occitanie, Nouvelle-Aquitaine), Polepharma anime ses adhérents partout en France.
Ce sont des laboratoires, fournisseurs, écoles, collectifs, experts, talents qui veulent faire de la France le meilleur endroit au monde où développer & produire des médicaments, c’est-à-dire à la pointe, vertueux, attractif pour le business et les talents.
Fabriquer des traitements de qualité en France, préventifs & curatifs, dans les meilleures conditions, sécurise notre santé à tous, contribue à l’emploi et aux économies locales.
La France s’est fixé pour priorité d’assurer sa souveraineté sanitaire.
Pour y arriver, elle doit regagner son leadership européen et accélérer la transition de son industrie (bio)pharmaceutique. Seule une action collective, permettra de relever ces défis.
AUDACE, FIERTÉ ET COOPÉRATION
Cluster, Mise en relation, and Industrie Pharmaceutique
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Aspen Pharma Group Pharmaceutical, Pharmaceutical Manufacturing | Aspen Pharma Group Pharmaceutical, Pharmaceutical Manufacturing | Other 11 May 2021 8 Mar 2023 | | |
Pôle TES Public business cluster, French Cluster, Business Consulting and Services | Pôle TES Public business cluster, French Cluster, Business Consulting and Services | Other 24 Sep 2023 | | |
Genopole Biotechnology, Biotechnology Research | Genopole Biotechnology, Biotechnology Research | Other 22 Jun 2021 7 Mar 2023 | | |
MAME Tours Events Services | MAME Tours Events Services | Other 8 Nov 2024 | | |
Waza Coworking Hospitality, Real Estate | Waza Coworking Hospitality, Real Estate | Other 16 Apr 2018 | | |
Normandie Incubation Professional Training & Coaching | Normandie Incubation Professional Training & Coaching | Other 1 Dec 2020 | | |
NWX - Normandie Web Xperts Software Development | NWX - Normandie Web Xperts Software Development | Other 28 May 2021 17 Mar 2024 | | |
France Clusters Non-profit Organizations | France Clusters Non-profit Organizations | Other 25 May 2021 16 Feb 2024 | | |
Cryoport Systems (formerly Cell&Co) Biotechnology, Pharmaceutical Manufacturing | Cryoport Systems (formerly Cell&Co) Biotechnology, Pharmaceutical Manufacturing | Other 4 Nov 2021 10 Apr 2024 | | |